Randomized, double-blind, phase II trial comparing gemcitabine-cisplatin plus the LTB4 antagonist LY293111 versus gemcitabine-cisplatin plus placebo in first-line non-small-cell lung cancer

  1. Jänne, P.A.
  2. Paz-Ares, L.
  3. Oh, Y.
  4. Eschbach, C.
  5. Hirsh, V.
  6. Enas, N.
  7. Brail, L.
  8. Von Pawel, J.
Aldizkaria:
Journal of Thoracic Oncology

ISSN: 1556-0864,  1556-1380

Argitalpen urtea: 2014

Alea: 9

Zenbakia: 1

Orrialdeak: 126-131

Mota: Artikulua

DOI: 10.1097/JTO.0000000000000037 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus